Latest Insider Transactions at Arcutis Biotherapeutics, Inc. (ARQT)
This section provides a real-time view of insider transactions for Arcutis Biotherapeutics, Inc. (ARQT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcutis Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcutis Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,468
-2.32%
|
$38,148
$11.12 P/Share
|
|
Mar 04
2024
|
Patrick J Heron Director |
BUY
Open market or private purchase
|
Indirect |
21,052
+0.24%
|
$189,468
$9.5 P/Share
|
|
Feb 28
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,465
-0.28%
|
$24,650
$10.6 P/Share
|
|
Feb 13
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94,898
+14.3%
|
-
|
|
Feb 13
2024
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
189,050
+14.91%
|
-
|
|
Feb 13
2024
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
264,882
+7.55%
|
-
|
|
Feb 13
2024
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
119,550
+18.47%
|
-
|
|
Feb 13
2024
|
John W Smither Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,365
+46.5%
|
-
|
|
Jan 12
2024
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+24.77%
|
-
|
|
Jan 12
2024
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+16.62%
|
-
|
|
Jan 12
2024
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+27.28%
|
-
|
|
Jan 12
2024
|
Larry Todd Edwards SVP Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+24.14%
|
-
|
|
Jan 12
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+33.9%
|
-
|
|
Jan 02
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
1,325
-2.27%
|
$3,975
$3.54 P/Share
|
|
Dec 20
2023
|
Todd Franklin Watanabe Director |
BUY
Bona fide gift
|
Indirect |
13,126
+21.19%
|
-
|
|
Dec 20
2023
|
Todd Franklin Watanabe Director |
SELL
Bona fide gift
|
Direct |
13,126
-1.28%
|
-
|
|
Dec 01
2023
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
59,525
+10.38%
|
$59,525
$1.68 P/Share
|
|
Nov 21
2023
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,850
-3.82%
|
$1,850
$1.98 P/Share
|
|
Nov 18
2023
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+9.14%
|
-
|
|
Oct 24
2023
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
80,000
+0.9%
|
$160,000
$2.5 P/Share
|
|
Sep 27
2023
|
Larry Todd Edwards SVP Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Aug 21
2023
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
1,605
-1.34%
|
$11,235
$7.05 P/Share
|
|
May 31
2023
|
Todd Franklin Watanabe Director |
BUY
Open market or private purchase
|
Direct |
1,463
+0.28%
|
$8,778
$6.38 P/Share
|
|
May 31
2023
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,463
+3.25%
|
$8,778
$6.38 P/Share
|
|
May 31
2023
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,830
-4.16%
|
$12,810
$7.8 P/Share
|
|
May 31
2023
|
Sue Jean Lin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+32.74%
|
-
|
|
May 31
2023
|
Patrick J Heron Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+33.49%
|
-
|
|
May 31
2023
|
Terrie Curran Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+33.49%
|
-
|
|
May 31
2023
|
Bhaskar Chaudhuri Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+0.51%
|
-
|
|
May 31
2023
|
Halley E Gilbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+33.49%
|
-
|
|
May 31
2023
|
Keith R Leonard Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+33.49%
|
-
|
|
May 31
2023
|
Neha Krishnamohan Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+43.83%
|
-
|
|
May 31
2023
|
Howard G. Welgus Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,375
+2.51%
|
-
|
|
May 27
2023
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+9.98%
|
-
|
|
Apr 17
2023
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
8,500
-4.88%
|
$110,500
$13.97 P/Share
|
|
Apr 17
2023
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+4.65%
|
$8,500
$1.68 P/Share
|
|
Apr 06
2023
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
8,500
-4.88%
|
$102,000
$12.01 P/Share
|
|
Apr 06
2023
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+4.65%
|
$8,500
$1.68 P/Share
|
|
Mar 06
2023
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,435
-0.66%
|
$36,525
$15.26 P/Share
|
|
Mar 06
2023
|
Kenneth A. Lock Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
831
-1.29%
|
$12,465
$15.26 P/Share
|
|
Mar 06
2023
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
690
-0.26%
|
$10,350
$15.26 P/Share
|
|
Mar 06
2023
|
Patricia A. Turney SVP, Operations |
SELL
Open market or private sale
|
Direct |
831
-1.3%
|
$12,465
$15.26 P/Share
|
|
Mar 06
2023
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
851
-1.4%
|
$12,765
$15.26 P/Share
|
|
Mar 06
2023
|
Scott L Burrows Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
291
-0.49%
|
$4,365
$15.26 P/Share
|
|
Mar 02
2023
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,900
+35.91%
|
-
|
|
Mar 02
2023
|
Matthew Richard Moore SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,610
-6.06%
|
$25,760
$16.17 P/Share
|
|
Mar 02
2023
|
Patricia A. Turney SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+22.03%
|
-
|
|
Mar 02
2023
|
David W Osborne Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,900
+5.24%
|
-
|
|
Mar 02
2023
|
Kenneth A. Lock Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+24.63%
|
-
|
|
Mar 02
2023
|
Scott L Burrows Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+26.12%
|
-
|